Skip to content
Home/Companies/Pharma/Wilson Therapeutics AB

Wilson Therapeutics AB

Pharma·Sweden·Exited 2018·Held 6yr
Entry
2012
Hold
6yr
Exit
2018

Who owns Wilson Therapeutics AB?

Wilson Therapeutics AB was owned by HealthCap through HealthCap VI (2008 vintage) from 2012 to 2018, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-18

HealthCap
Investor
HealthCap
HealthCap VI · 2008 · VC

Key facts

HQSweden
SectorPharma
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2018

More from HealthCap VI

Other portfolio companies in the same fund.

GenSight Biologics S.A.
Exited 2016
BiotechFrance· 2015
Glionova AB
Active
BiotechSweden· 2014
Xeris Biopharma Holdings, Inc (Strongbridge)
Exited 2021
PharmaUS· 2014
to
Nordic Nanovector AS
Exited 2015
BiotechNO· 2013
Oncopeptides AB
Exited 2017
BiotechSE· 2013
Ultragenyx
Exited 2014
BiotechUS· 2011

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Wilson Therapeutics AB

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Wilson Therapeutics AB?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Wilson Therapeutics AB.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue